ENZYME-IMMUNOASSAY - AN IMPROVED DETERMINATION OF URINARY ALBUMIN IN DIABETICS WITH INCIPIENT NEPHROPATHY
ENZYME-IMMUNOASSAY - AN IMPROVED DETERMINATION OF URINARY ALBUMIN IN DIABETICS WITH INCIPIENT NEPHROPATHY
复制标题
DOI:
10.3109/00365518509155256
复制
发表时间:
1985-01-01
影响因子:
2.1
通讯作者:
DECKERT, M
中科院分区:
文献类型:
--
作者:
FELDTRASMUSSEN, B;DINESEN, B;DECKERT, M
An enzyme linked immunoadsorbent assay for urinary albumin using commercially available reagents is described. The assay range is 2.5-120 .mu.g/1. When samples are analysed in two standard dilutions, the assayable albumin concentration range is 2.5-240 mg/l, covering the clinical range from normoalbuminuria to overt clinical nephropathy. Intra-assay variation was 2.1% and interassay variation 8.3%. Recovery of added albumin to urine was 95%-106% and dilution of urine was linear. The correlation to urinary albumin determined by immunodiffusion was excellent (n=80, r=0.99). Intraindividual variation of the 24 h urine albumin excretion of different days was high in patients with incipient diabetic nephropathy (51.5%) and was only slightly reduced by taking the variation of creatinine excretion into account (39.5%). No correlation was found between albumin excretion, and HbA1c or urine glucose excretion, indicating that minor metabolic variations are not responsible for the huge intraindividual day-to-day variations of UalbV. The study shows that more than one UalbV measurement must be done before classifying patients into groups with or without incipient diabetic nephropathy.